Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Michael Burry who wrote (3939)	4/28/1998 9:49:00 AM
From: James Clarke	Respond to of 78465

re: Tobaccos. Get Barrons from over the weekend and look in the interview they did with Kurt Feurman of Morgan Stanley. He gives a great bull case on tobaccos.

To: Michael Burry who wrote (3939)	4/28/1998 11:57:00 AM
From: Bob Varney	Respond to of 78465

I've been looking at MO to buy as a covered call - ie, buy the stock and sell the call out the dividend period. I know some of the people who did the Wellbutrin studies. They believe in it. I was concerned about the typical antidepressant side effects. Note that there is a big TV ad campaign right now. Have you given any prescriptions for it? If so, is there OK patient acceptance without lots of theraputic support? My sense from the study people was that support group was a key. I know Wall Street has a stiffy for Viagra, but I would question whether it is a fad. It is not an elegent solution. Maybe if I needed it, it would seem more appealing. The key is who pays? Bob

To: Michael Burry who wrote (3939)	4/28/1998 7:40:00 PM
From: Jurgis Bekepuris	Read Replies (1) \| Respond to of 78465

Hey guys, P/book and P/sales just declared useless by Fool: fnews.yahoo.com I guess it's time to focus on the wild success stories like Amazon.com. Still nobody interested in Dollar-for-99c? Message 4210891 :-)))) Jurgis

To: Michael Burry who wrote (3939)	4/28/1998 9:18:00 PM
From: Robert Hoefer	Respond to of 78465

MO and UST not as good an idea as RN (RJR Nabisco). Here's why: with bonds of bankrupt companies, you make the most money by buying the lowest priority bond that is likely to get any payout. Quality is low, but not too low (you hope), but the price is highly discounted. MO is the quality company, but you won't make as much as on RN. Less than book, half sales, div. of 7%+, and a potential spinoff of Nabisco. So be brave, buy the lower quality company, and pray it survives (it will). The total return will make the extra risk worth it.

To: Michael Burry who wrote (3939)	4/30/1998 1:38:00 PM
From: Wright Sullivan	Read Replies (1) \| Respond to of 78465

Here's an oxymoron: A cheap internet value stock with real profits and recent growth around 100%/year. CHKPF Checkpoint Software Technology - CHKPF is no.1 in network firewall software (40% market share), a real live "gorilla". - Earnings announced were way up and well above predictions. - This is an internet stock which actually makes money. - CHKPF firewall sales split about 50% on Unix, 50% on Win NT. - Stock price slammed lately, to as low as $29 today, partially due to a single comment from Microsoft's Ballmer, saying that MSFT plans to beef up their Proxy Server, which in some ways overlaps with CHKPF's software. Maybe this one is too tech or whatever, but I think that at current prices CHKPF is a value stock, not just the usual internet momentum garbage.